Showing 8091-8100 of 18602 results for "".
Precision Medicine in RA: A New Test for Predicting Anti-TNF Therapies
https://reachmd.com/programs/conference-coverage/precision-medicine-in-ra-a-new-test-for-predicting-anti-tnf-therapies/10297/What’s currently missing in rheumatology is a precision medicine test, but researchers are optimistic about a new find that could meet that need.The Emotional Toll of Psoriatic Skin Lesions
https://reachmd.com/programs/beyond-skin-deep/the-emotional-toll-of-psoriatic-skin-lesions/10138/Psoriatic arthritis doesn’t just affect patients physically—it takes an emotional toll as well. Learn how you can help your patients through it.Could You Be Missing Symptoms in Your PsA Patients?
https://reachmd.com/programs/beyond-skin-deep/could-you-be-missing-symptoms-in-your-psa-patients/10149/Detecting poor symptom control is key in treating PsA, but what about when your patient doesn’t reveal all of their symptoms?Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
https://reachmd.com/programs/project-oncology/not-quite-a-cancer-vaccine-selling-hpv-and-cervical-cancer/10028/Samantha Gottlieb traces the medical, social, and political controversies in the ten years following the HPV vaccine's launch.Addressing the Unique Challenges of Opioid Use Disorder in Women
https://reachmd.com/programs/grand-rounds-nation/addressing-unique-challenges-opioid-use-disorder-women/8506/The CDC discusses the complexities of opioid use disorder among women, federal responses to the disorder, and approaches to care and prevention.Meet Matt Birnholz, MD
https://reachmd.com/programs/meet-the-host/meet-matt-birnholz-md/8480/Get to know Dr. Matt Birnholz, host and medical director for ReachMD.Tissue-Specific Protein Clusters May Help Predict Risk of Alzheimer’s Disease
https://reachmd.com/programs/Audioabstracts/tissue-specific-protein-clusters-may-help-predict-risk-alzheimers-disease/8296/A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease.Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?
https://reachmd.com/programs/lipid-luminations/pharmacometabolomics-to-predict-statin-response-ready-for-prime-time/8342/Dr. Cooper-DeHoff discusses the rise of pharmacometabolomics, genomic testing, and pharmacogenetic testing in lipidology.Beyond the Blood Spot: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease
https://reachmd.com/programs/grand-rounds-nation/beyond-blood-spot-newborn-screening-hearing-loss-and-critical-congenital-heart-disease/8360/The CDC examines point-of-care newborn screening and what challenges have been faced in standardizing these tests across the nation.The Rise of Specialist-Driven Alternative Payment Models in American Medicine
https://reachmd.com/programs/perspectives-ama/rise-specialist-driven-alternative-payment-models-american-medicine/8241/Dr. Lawrence Kosinski, founder and Chief Medical Officer for SonarMD, discusses the critical emergence of specialist-driven APM platforms.